ChlVPP chemotherapy in advanced Hodgkin's disease
- 1 March 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (3) , 557-561
- https://doi.org/10.1016/0277-5379(89)90270-8
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Twenty years of MOPP therapy for Hodgkin's disease.Journal of Clinical Oncology, 1986
- MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.Journal of Clinical Oncology, 1985
- BCVPP Chemotherapy for Advanced Hodgkin's Disease: Evidence for Greater Duration of Complete Remission, Greater Survival, and Less Toxicity Than with a MOPP RegimenAnnals of Internal Medicine, 1984
- ABVD chemotherapy in the treatment of Hodgkin's diseaseCancer Treatment Reviews, 1982
- Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's diseaseBritish Journal of Cancer, 1979
- MVPP chemotherapy regimen for advanced Hodgkin's diseaseBMJ, 1978
- A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's diseaseBritish Journal of Cancer, 1977
- New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's diseaseCancer, 1976
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1970
- Combination Chemotherapy in Generalized Hodgkin's DiseaseBMJ, 1970